Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Pfizer and Roivant launch autoimmune specialist Priovant

US panel backs Omicron-targeting vaccines for booster campaigns

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

NHS App could offer video consultations by 2024

Novartis will shed 7% of workforce in restructuring, say reports

Real Chemistry

Mary_Stutts_Preferred

Appointments/ News/ News/ News

Real Chemistry hires new global chief inclusion and health equity officer

Catherine Longworth comms, diversity, diversity and inclusion, Real Chemistry 0 Comment

Global health innovation company Real Chemistry has announced the appointment of Mary Stutts to lead its diversity, equity

X

Real Chemistry hires new global chief inclusion and health equity officer

https://pharmaphorum.com/news/real-chemistry-hires-new-global-chief-inclusion-and-health-equity-officerd/

digital pharma marketing revolution

News/ News/ Sales and Marketing

W20 rebrands as Real Chemistry

Richard Staines comms, Real Chemistry 0 Comment

Healthcare marketing and communications firm W20 has rebranded as Real Chemistry, a move it says reflects its purpose

X

W20 rebrands as Real Chemistry

https://pharmaphorum.com/news/w20-rebrands-as-real-chemistry/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Ipsen beefs up in oncology, buying US biopharma Epizyme
GSK hepatitis B hope bepirovirsen heads for phase 3 test
Novartis will shed 7% of workforce in restructuring, say reports
Another Astellas gene therapy hits a safety hurdle
BioMarin gene therapy for haemophilia on course for EU approval

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com